Fredun Pharma

71
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
2,610.00
-0.15 (-0.01%)
BSENSE

Jun 18

BSE+NSE Vol: 13.76 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Fredun Pharma Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
No of Months
12
12
Profit Before Tax
32.00
20.00
Adjustment
48.00
35.00
Changes In working Capital
-67.00
-71.00
Cash Flow after changes in Working Capital
12.00
-16.00
Cash Flow from Operating Activities
11.00
-16.00
Cash Flow from Investing Activities
-73.00
-6.00
Cash Flow from Financing Activities
121.00
26.00
Net Cash Inflow / Outflow
59.00
3.00
Opening Cash & Cash Equivalents
5.00
1.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
Closing Cash & Cash Equivalent
64.00
5.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Fredun Pharma
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
32.62
34.59
-2.00
-5.70%
Adjustment
48.22
-40.31
88.00
219.62%
Changes In working Capital
-67.93
-19.76
-48.00
-243.78%
Cash Flow after changes in Working Capital
12.91
-25.47
37.00
150.69%
Cash Flow from Operating Activities
11.9
-25.47
36.00
146.72%
Cash Flow from Investing Activities
-73.59
-110.2
37.00
33.22%
Cash Flow from Financing Activities
121.45
69.2
52.00
75.51%
Net Cash Inflow / Outflow
59.76
-66.47
125.00
189.91%
Opening Cash & Cash Equivalents
5.22
493.93
-488.00
-98.94%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
64.98
427.46
-363.00
-84.80%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 171.69% vs NA in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
11.90
-16.60
171.69%